期刊文献+

临床药师参与1例肺孢子菌肺炎患者的病例分析

Clinical Pharmacist Participating in a Case Analysis of a Patient with Pneumocystis Pneumonia
下载PDF
导出
摘要 目的 探讨临床药师在肺孢子菌肺炎患者治疗中的作用。方法 临床药师参与1例非HIV患者合并肺孢子菌肺炎的诊疗全过程,主要研究在免疫力低下的非HIV患者CD4计数正常时,感染肺孢子菌肺炎(Pneumocystis pneumonia,PCP)的临床诊断及治疗方案,同时在治疗过程中临床药师建议对患者使用激素治疗。结果 临床药师的建议得到医生的采纳,患者病情稳定后转出重症医学科(ICU),后经治疗后好转出院。结论 临床药师在治疗过程中可以协助医师进行治疗方案的调整,包括抗感染治疗和激素的使用,能发挥自身的价值,更好地促进患者的合理用药。 OBJECTIVE To explore the role of clinical pharmacists in the treatment of patients with Pneumocystis pneumonia.METHODS Clinical pharmacists participated in the whole process of diagnosis and treatment of a non-HIV patient complicated with Pneumocystis pneumonia.The main research was on the clinical diagnosis and treatment of Pneumocystis pneumonia( PCP) in immunocompromised non-HIV patients with normal CD4 count.At the same time,the clinical pharmacist recommended the use of hormone therapy for the patient during the treatment process.RESULTS The clinical pharmacist’ s suggestion was accepted by the doctor.The patient was transferred out of the intensive care unit( ICU) after the patient’ s condition was stable,and was discharged after treatment.CONCLUSION Clinical pharmacists can assist physicians in adjusting the treatment plan,including anti-infective therapy and hormone use,which can exert their own value and better promote the rational drug use of patients.
作者 白意晓 杨明 刘鹏 彭瑞光 母育成 涂爱萍 冯国纹 BAI Yi-xiao;YANG Ming;LIU Peng;PENG Rui-guang;MU Yu-chen;TU Ai-ping;FENG Guo-wen(Department of Pharmacy,Langzhong People′s Hospital,Langzhong 637400,China;Department of Pharmacy,Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China)
出处 《海峡药学》 2022年第10期87-90,共4页 Strait Pharmaceutical Journal
关键词 临床药师 PCP 抗感染 CD4计数 激素治疗 Clinical pharmacist Pneumocystis pneumonia(PCP) Anti-infection CD4 count Hormone therapy
  • 相关文献

参考文献3

二级参考文献19

  • 1中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2011版)[J].中华临床感染病杂志,2011,4(6). 被引量:380
  • 2朱文科,陆普选,余卫业,刘艳,刘水腾,刘锦清,苏坚,乐晓华,周伯平.艾滋病合并肺结核的CT表现与CD4T淋巴细胞的关系[J].中国医学影像学杂志,2007,15(4):256-259. 被引量:9
  • 3Hui M, Kwok WT. Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study[J]. J Med Mirobiol, 2006, 55(Pt 1):85-88.
  • 4Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indica tors for the diagnosis of pneumocystis pneumonia[J]. Chest, 2007,131(4) :1173-1180.
  • 5Watanabe T, Yasuoka A, Tanuma J, et al. Serum (1→3) beta D-glucan as a noninvasive adjunct marker for the diagno sis of Pneumoeystis pneumonia in patients with AIDS[J]. Clin Infect Dis, 2009, 49(7):1128-1131.
  • 6Iikuni N, Kitahama M, Ohta S, et al. Evaluation of Pneu mocystis pneumonia infection risk factors in patients with connective tissue disease{J]. Mod Rheumatol, 2006,16(5) : 282-288.
  • 7Gluck T,Geerdes Fenge HF,Straub RH,et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy[J]. Infection, 2000,289 (4) : 227 -230.
  • 8Hof H, Schnulle P. Pneumoeystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin[J]. Mycoses, 2008, 51 (Suppl 1), 65-67.
  • 9Utili R, Durante Mangoni E, Basilieo C, et al. Efficacy of caspofungin addition to trimethoprim sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients [J]. Transplantation, 2007, 84 (6): 685-688.
  • 10陈秀萍,黄湛镰.艾滋病合并卡氏肺孢子虫肺炎的胸部影像学分析[J].实用临床医学(江西),2007,8(10):100-101. 被引量:5

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部